retatrutide benefits Eli Lilly's shows promising weight loss results in phase 3 trial Retatrutide Benefits: What We Know

4, 2023, pp

The most striking protective effects of SGLT2is were a marked reduction in hospitalization for heart failure and a remarkable reduced progression of chronic kidney disease

Do they actually make a difference

Examples of GLP-1s include semaglutide (Wegovy), and liraglutide (Saxenda)

Phase 2 Initiation Targeted for Second Half of 2025 Overview of key poster abstracts Hanmi will present at ADA 2025 (Source: Hanmi Pharmaceutical homepage) (June 10, 2025) Hanmi Pharmaceutical is set to unveil a series of breakthrough research results on its next-generation, game-changing obesity drug candidates that overcome the inherent limitations of GLP-1-based therapies, including inevitable muscle loss, at one of the worlds most prestigious metabolic disease conferences